Review



cjun cjun 60a8 rabbit mab  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc cjun cjun 60a8 rabbit mab
    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of <t>cJUN</t> (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).
    Cjun Cjun 60a8 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1497 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cjun+60a8/pmc12287255-124-19-25?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1497 article reviews
    cjun cjun 60a8 rabbit mab - by Bioz Stars, 2026-07
    96/100 stars

    Images

    1) Product Images from "The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma"

    Article Title: The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma

    Journal: Scientific Reports

    doi: 10.1038/s41598-025-07393-9

    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of cJUN (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).
    Figure Legend Snippet: Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of cJUN (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).

    Techniques Used: Expressing

    Immunohistochemistry (IHC) of cJUN and JUNB in esophageal adenocarcinoma. In total, 735 patient samples were stained for cJUN and JUNB. Representative immunohistochemistry pictures are shown: Top, cJUN IHC for a positive (left) and a negative sample (right). Bottom, JUNB IHC for a positive (left) and a negative sample (right). Magnification 20X.
    Figure Legend Snippet: Immunohistochemistry (IHC) of cJUN and JUNB in esophageal adenocarcinoma. In total, 735 patient samples were stained for cJUN and JUNB. Representative immunohistochemistry pictures are shown: Top, cJUN IHC for a positive (left) and a negative sample (right). Bottom, JUNB IHC for a positive (left) and a negative sample (right). Magnification 20X.

    Techniques Used: Immunohistochemistry, Staining

    JUNB expression is a marker for poor outcome in patients with multimodal therapy. Survival analysis for the multimodally-treated patients using Kaplan-Meyer curves . ( A ) Low (n = 318) or high expression (n = 147) of cJUN (p = 0.078), and ( B ) low (n = 367) or high expression (n = 112) of JUNB is shown (p = 0.006).
    Figure Legend Snippet: JUNB expression is a marker for poor outcome in patients with multimodal therapy. Survival analysis for the multimodally-treated patients using Kaplan-Meyer curves . ( A ) Low (n = 318) or high expression (n = 147) of cJUN (p = 0.078), and ( B ) low (n = 367) or high expression (n = 112) of JUNB is shown (p = 0.006).

    Techniques Used: Expressing, Marker

    The combined expression of cJUN and JUNB correlates to the poorest outcome in esophageal adenocarcinoma. Survival analysis for the combined expression of cJUN and JUNB compared to either one of the two factors positive or none at all. ( A ) Overall cohort, negative (n = 370), cJUN or JUNB positive (n = 217) as well as cJUN and JUNB positive (n = 66) expression is shown (p = 0.012). ( B ) Primary surgery, negative (n = 123), cJUN or JUNB positive (n = 66) as well as cJUN and JUNB positive (n = 22) expression is shown (p = 0.774). ( C ) Multimodally-treated cohort, negative (n = 247), cJUN or JUNB positive (n = 44) as wells as cJUN and JUNB positive (n = 66) expression is shown (p = 0.003).
    Figure Legend Snippet: The combined expression of cJUN and JUNB correlates to the poorest outcome in esophageal adenocarcinoma. Survival analysis for the combined expression of cJUN and JUNB compared to either one of the two factors positive or none at all. ( A ) Overall cohort, negative (n = 370), cJUN or JUNB positive (n = 217) as well as cJUN and JUNB positive (n = 66) expression is shown (p = 0.012). ( B ) Primary surgery, negative (n = 123), cJUN or JUNB positive (n = 66) as well as cJUN and JUNB positive (n = 22) expression is shown (p = 0.774). ( C ) Multimodally-treated cohort, negative (n = 247), cJUN or JUNB positive (n = 44) as wells as cJUN and JUNB positive (n = 66) expression is shown (p = 0.003).

    Techniques Used: Expressing



    Similar Products

    cjun cjun 60a8 rabbit mab  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc cjun cjun 60a8 rabbit mab
    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of <t>cJUN</t> (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).
    Cjun Cjun 60a8 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cjun+60a8/pmc12287255-124-19-25?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    cjun cjun 60a8 rabbit mab - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    cjun c jun 60a8 rabbit mab cst  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc cjun c jun 60a8 rabbit mab cst
    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of <t>cJUN</t> (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).
    Cjun C Jun 60a8 Rabbit Mab Cst, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cjun+60a8/pm40699751-852-229-234?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    cjun c jun 60a8 rabbit mab cst - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    cjun 60a8  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc cjun 60a8
    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of <t>cJUN</t> (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).
    Cjun 60a8, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cjun+60a8/bio_rxiv__2024__11__11__623044-204-12-14?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    cjun 60a8 - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    rabbit anti cjun 60a8  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc rabbit anti cjun 60a8
    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of <t>cJUN</t> (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).
    Rabbit Anti Cjun 60a8, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cjun+60a8/pmc11390485-410-98-101?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    rabbit anti cjun 60a8 - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    cjun 60a8 rabbit mab 9165  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc cjun 60a8 rabbit mab 9165
    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of <t>cJUN</t> (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).
    Cjun 60a8 Rabbit Mab 9165, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cjun+60a8/pm36738826-74-34-89?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    cjun 60a8 rabbit mab 9165 - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    rabbit mab cell signaling technology 60a8 phospho cjun ser73  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc rabbit mab cell signaling technology 60a8 phospho cjun ser73
    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of <t>cJUN</t> (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).
    Rabbit Mab Cell Signaling Technology 60a8 Phospho Cjun Ser73, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cjun+60a8/pmc08507201__mmc1-31-67-69?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    rabbit mab cell signaling technology 60a8 phospho cjun ser73 - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    cjun 60a8 cst cat 9165  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc cjun 60a8 cst cat 9165
    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of <t>cJUN</t> (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).
    Cjun 60a8 Cst Cat 9165, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+cjun+60a8/pmc06218936-193-23-24?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    cjun 60a8 cst cat 9165 - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of cJUN (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).

    Journal: Scientific Reports

    Article Title: The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma

    doi: 10.1038/s41598-025-07393-9

    Figure Lengend Snippet: Expression of JUNB correlates to poor overall survival in esophageal adenocarcinoma. Kaplan-Meyer curves of the overall survival in the total cohort depending on ( A ) Low (n = 481) or high expression (n = 208) of cJUN (p = 0.127), and ( B ) low (n = 530) or high expression (n = 170) of JUNB are shown (p = 0.006).

    Article Snippet: Immunohistochemical staining for cJUN and JUNB was carried out using the Leica Bond-MAX automated system (Leica Biosystems, Wetzlar, Germany). cJUN (cJUN (60A8) Rabbit mAB #9165, Cell Signaling Technologies, 1:250 dilution) and JUNB (JUNB (C37F9) Rabbit mAB #3753, Cell Signaling Technologies, 1:250 dilution) staining was performed.

    Techniques: Expressing

    Immunohistochemistry (IHC) of cJUN and JUNB in esophageal adenocarcinoma. In total, 735 patient samples were stained for cJUN and JUNB. Representative immunohistochemistry pictures are shown: Top, cJUN IHC for a positive (left) and a negative sample (right). Bottom, JUNB IHC for a positive (left) and a negative sample (right). Magnification 20X.

    Journal: Scientific Reports

    Article Title: The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma

    doi: 10.1038/s41598-025-07393-9

    Figure Lengend Snippet: Immunohistochemistry (IHC) of cJUN and JUNB in esophageal adenocarcinoma. In total, 735 patient samples were stained for cJUN and JUNB. Representative immunohistochemistry pictures are shown: Top, cJUN IHC for a positive (left) and a negative sample (right). Bottom, JUNB IHC for a positive (left) and a negative sample (right). Magnification 20X.

    Article Snippet: Immunohistochemical staining for cJUN and JUNB was carried out using the Leica Bond-MAX automated system (Leica Biosystems, Wetzlar, Germany). cJUN (cJUN (60A8) Rabbit mAB #9165, Cell Signaling Technologies, 1:250 dilution) and JUNB (JUNB (C37F9) Rabbit mAB #3753, Cell Signaling Technologies, 1:250 dilution) staining was performed.

    Techniques: Immunohistochemistry, Staining

    JUNB expression is a marker for poor outcome in patients with multimodal therapy. Survival analysis for the multimodally-treated patients using Kaplan-Meyer curves . ( A ) Low (n = 318) or high expression (n = 147) of cJUN (p = 0.078), and ( B ) low (n = 367) or high expression (n = 112) of JUNB is shown (p = 0.006).

    Journal: Scientific Reports

    Article Title: The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma

    doi: 10.1038/s41598-025-07393-9

    Figure Lengend Snippet: JUNB expression is a marker for poor outcome in patients with multimodal therapy. Survival analysis for the multimodally-treated patients using Kaplan-Meyer curves . ( A ) Low (n = 318) or high expression (n = 147) of cJUN (p = 0.078), and ( B ) low (n = 367) or high expression (n = 112) of JUNB is shown (p = 0.006).

    Article Snippet: Immunohistochemical staining for cJUN and JUNB was carried out using the Leica Bond-MAX automated system (Leica Biosystems, Wetzlar, Germany). cJUN (cJUN (60A8) Rabbit mAB #9165, Cell Signaling Technologies, 1:250 dilution) and JUNB (JUNB (C37F9) Rabbit mAB #3753, Cell Signaling Technologies, 1:250 dilution) staining was performed.

    Techniques: Expressing, Marker

    The combined expression of cJUN and JUNB correlates to the poorest outcome in esophageal adenocarcinoma. Survival analysis for the combined expression of cJUN and JUNB compared to either one of the two factors positive or none at all. ( A ) Overall cohort, negative (n = 370), cJUN or JUNB positive (n = 217) as well as cJUN and JUNB positive (n = 66) expression is shown (p = 0.012). ( B ) Primary surgery, negative (n = 123), cJUN or JUNB positive (n = 66) as well as cJUN and JUNB positive (n = 22) expression is shown (p = 0.774). ( C ) Multimodally-treated cohort, negative (n = 247), cJUN or JUNB positive (n = 44) as wells as cJUN and JUNB positive (n = 66) expression is shown (p = 0.003).

    Journal: Scientific Reports

    Article Title: The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma

    doi: 10.1038/s41598-025-07393-9

    Figure Lengend Snippet: The combined expression of cJUN and JUNB correlates to the poorest outcome in esophageal adenocarcinoma. Survival analysis for the combined expression of cJUN and JUNB compared to either one of the two factors positive or none at all. ( A ) Overall cohort, negative (n = 370), cJUN or JUNB positive (n = 217) as well as cJUN and JUNB positive (n = 66) expression is shown (p = 0.012). ( B ) Primary surgery, negative (n = 123), cJUN or JUNB positive (n = 66) as well as cJUN and JUNB positive (n = 22) expression is shown (p = 0.774). ( C ) Multimodally-treated cohort, negative (n = 247), cJUN or JUNB positive (n = 44) as wells as cJUN and JUNB positive (n = 66) expression is shown (p = 0.003).

    Article Snippet: Immunohistochemical staining for cJUN and JUNB was carried out using the Leica Bond-MAX automated system (Leica Biosystems, Wetzlar, Germany). cJUN (cJUN (60A8) Rabbit mAB #9165, Cell Signaling Technologies, 1:250 dilution) and JUNB (JUNB (C37F9) Rabbit mAB #3753, Cell Signaling Technologies, 1:250 dilution) staining was performed.

    Techniques: Expressing